ArticleThe mental health clinician2016

Intolerance of sublingual buprenorphine-naloxone during induction in a patient with end-stage liver disease: A case report.

Jennifer Behan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.